Abstract:[Objective] To evaluate the expressions of thyroid stimulating hormone receptor(TSHR) and matrix metalloproteinase-9(MMP-9) in papillary thyroid carcinoma(PTC) and their clinical significances.[Method] The SP immunohistochemistry was used to detect the expressions of TSHR and MMP-9 protein in 56 cases of PTC,30 cases of nodular goiter and 11 cases of normal thyroid tissue.[Results] The positive expression rate of TSHR in PTC was significantly higher than those of nodular goiter and normal thyroid tissue(P0.05).and the rates in PTC with lymph node metastasis and without were 76.92% and 95.35% respectively(P0.05),The rates in stage Ⅲ-Ⅳand stageⅠ-Ⅱwere 89.66 % and 92.60 % respectively(P0.05);The positive expression rate of MMP-9 protein in PTC was significantly higher than those of nodular goiter and normal thyroid tissue(P0.05).and the rates in PTC with lymph node metastasis and without were 92.31 % and 79.07 % respectively(P0.05),and the rates in stage Ⅲ-Ⅳand stageⅠ-Ⅱwere 89.66 % and 74.07 % respectively(P0.05).Their expressions of both TSHR and MMP-9 were not related to sex,age and tumor size of the patient(P0.05).[Conclusion] Over-expression of TSHR might be related to the development of PTC and become a early marker of the thyroid carcinoma.The over-expression of MMP-9 could be related to invasion and metastasis.

Clinical Significances of the TSHR and MMP-9 Expressions in Papillary Thyroid Carcinoma